Aleafia Health Inc.
ALEAF
$0.00
$0.000.00%
| 03/31/2023 | 12/31/2022 | 09/30/2022 | 06/30/2022 | 03/31/2022 | |
|---|---|---|---|---|---|
| Revenue | 19.10% | 2.21% | 4.67% | 19.88% | 25.54% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 19.10% | 2.21% | 4.67% | 19.88% | 25.54% |
| Cost of Revenue | -21.58% | -48.89% | -10.50% | 16.86% | -1.96% |
| Gross Profit | 170.21% | 212.32% | 286.10% | -8.84% | 45.54% |
| SG&A Expenses | -38.54% | -43.71% | -34.59% | -26.15% | 2.75% |
| Depreciation & Amortization | -57.69% | -21.99% | 0.56% | -11.42% | 2.29% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -31.38% | -44.80% | -20.63% | -3.64% | 0.18% |
| Operating Income | 66.88% | 76.97% | 40.80% | 16.77% | 12.29% |
| Income Before Tax | 76.72% | 93.96% | 80.99% | 39.42% | 45.73% |
| Income Tax Expenses | -- | 119.89% | 703.35% | -63.95% | 17.09% |
| Earnings from Continuing Operations | 76.33% | 93.49% | 80.80% | 40.01% | 46.04% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 76.33% | 93.49% | 80.80% | 40.01% | 46.04% |
| EBIT | 66.88% | 76.97% | 40.80% | 16.77% | 12.29% |
| EBITDA | 73.35% | 87.33% | 53.26% | 21.48% | 16.04% |
| EPS Basic | 80.03% | 95.82% | 81.95% | 45.67% | 51.04% |
| Normalized Basic EPS | 62.53% | 69.59% | 34.72% | 21.61% | 22.53% |
| EPS Diluted | 80.03% | 95.82% | 81.95% | 45.67% | 51.04% |
| Normalized Diluted EPS | 62.53% | 69.59% | 34.72% | 21.61% | 22.53% |
| Average Basic Shares Outstanding | 18.66% | 12.61% | 9.57% | 6.41% | 9.26% |
| Average Diluted Shares Outstanding | 18.66% | 12.61% | 9.57% | 6.41% | 9.26% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |
